Related content

Pre-treatment and post-treatment assessment of the C₆ test in patients with persistent symptoms and a history of Lyme borreliosis

By Fleming R.   Marques A.   Klempner M.   Schmid C.   Dally L.   Martin D.   Philipp M.  

European Journal of Clinical Microbiology and Infectious Diseases, Vol. 23, Iss. 8, 2004-08 ,pp. : 615-618

Springer Publishing Company

Access to resources Recommend Favorite

Duration of antibiotic treatment in disseminated Lyme borreliosis: a double-blind, randomized, placebo-controlled, multicenter clinical study

By Oksi J.   Nikoskelainen J.   Hiekkanen H.   Lauhio A.   Peltomaa M.   Pitkäranta A.   Nyman D.   Granlund H.   Carlsson S.-A.   Seppälä I.   Valtonen V.   Viljanen M.  

European Journal of Clinical Microbiology and Infectious Diseases, Vol. 26, Iss. 8, 2007-08 ,pp. : 571-581

Springer Publishing Company

Access to resources Recommend Favorite

Differential diagnoses of suspected Lyme borreliosis or post-Lyme-disease syndrome

By Seidel M.   Domene A.   Vetter H.  

European Journal of Clinical Microbiology and Infectious Diseases, Vol. 26, Iss. 9, 2007-09 ,pp. : 611-617

Springer Publishing Company

Access to resources Recommend Favorite

C6 peptide ELISA test in the serodiagnosis of Lyme borreliosis in Sweden

By Tjernberg I.   Krüger G.   Eliasson I.  

European Journal of Clinical Microbiology and Infectious Diseases, Vol. 26, Iss. 1, 2007-01 ,pp. : 37-42

Springer Publishing Company

Access to resources Recommend Favorite

Lyme borreliosis (Lyme disease): interactions of Borrelia burgdorferi sensu lato with human (and other mammalian) hosts

By Sigal L.H.  

Institut Pasteur. Bulletin, Vol. 96, Iss. 3, 1998-07 ,pp. : 189-206

Elsevier

Access to resources Recommend Favorite